Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases
- PMID: 185553
Malignant mixed germ cell tumors of the ovary. A clinical and pathologic analysis of 30 cases
Abstract
The clinical and pathologic features of 30 ovarian mixed germ cell tumors (neoplasms containing combinations of malignant germ cell elements) were studied to determine their behavior and to compare them with pure forms of malignant germ cell tumors. Dysgerminoma was the most common constituent, found in 24 (80%), followed by endodermal sinus tumor in 21 (70%), teratoma in 16 (53%), choriocarcinoma in 6 (20%), and embryonal carcinoma in 5 (16%). The actuarial survival for the entire group was 46%, and for patients with Stage I tumors it was 50%. The most important factors in predicting the prognosis for patients with Stage I disease was the size and the histologic composition of the neoplasm. If more than one-third of a Stage I neoplasm was composed of endodermal sinus tumor, choriocarcinoma, or Grade 3 teratoma, the prognosis was poor, whereas if the tumor contained less than one-third of these components or contained combinations of dysgerminoma, embryonal carcinoma, or Grade 1 or 2 teratoma, the prognosis was excellent. All patients whose neoplasm was less than 10 cm in maximum diameter survived, regardless of the composition of the tumor. Positive pregnancy tests in nonpregnant patients reflected the presence of either frank choriocarcinoma or scattered syncytiotrophoblastic giant cells. The latter did not appear to alter the prognosis. The finding of elevated serum levels of human chorionic gonadotropin (hCG) in 38% of the nonpregnant patients suggested that serial serum assays for hCG might be useful in staging and monitoring the response to treatment in these patients.
Similar articles
-
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.Mod Pathol. 2005 Feb;18 Suppl 2:S61-79. doi: 10.1038/modpathol.3800310. Mod Pathol. 2005. PMID: 15761467 Review.
-
[Characteristics of rare ovarian tumors--possibilities of organ preservation].Zentralbl Gynakol. 1996;118(6):322-5. Zentralbl Gynakol. 1996. PMID: 8768007 Review. German.
-
[The pathology of germ cell tumors of the ovary].Gan To Kagaku Ryoho. 1984 Dec;11(12 Pt 1):2479-88. Gan To Kagaku Ryoho. 1984. PMID: 6095759 Japanese.
-
Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.Cancer. 1997 Aug 15;80(4):699-707. Cancer. 1997. PMID: 9264353
-
Current management of malignant germ cell tumor of the ovary.Gan To Kagaku Ryoho. 1995 Aug;22 Suppl 3:262-76. Gan To Kagaku Ryoho. 1995. PMID: 7661594 Review.
Cited by
-
Hormone-producing tumors of the ovary.Endocr Pathol. 1990 Sep;1(3):132-171. doi: 10.1007/BF02915390. Endocr Pathol. 1990. PMID: 32138399 Review.
-
A Transplantable Syngeneic Allograft Mouse Model for Nongestational Choriocarcinoma of the Ovary.Vet Pathol. 2019 May;56(3):399-403. doi: 10.1177/0300985818823669. Epub 2019 Jan 13. Vet Pathol. 2019. PMID: 30636537 Free PMC article.
-
Alpha-fetoprotein, alpha-1-antitrypsin, and transferrin in gonadal yolk-sac tumours.J Clin Pathol. 1979 May;32(5):455-61. doi: 10.1136/jcp.32.5.455. J Clin Pathol. 1979. PMID: 89123 Free PMC article.
-
Mixed germ cell tumor of the ovary with sarcomatous component.Pathol Oncol Res. 2001;7(1):60-2. doi: 10.1007/BF03032607. Pathol Oncol Res. 2001. PMID: 11349223
-
A poor prognostic metastatic nongestational choriocarcinoma of the ovary: a case report and the literature review.J Ovarian Res. 2021 Apr 22;14(1):56. doi: 10.1186/s13048-021-00810-3. J Ovarian Res. 2021. PMID: 33888146 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources